CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Immunizations - travel vaccinations - Management
What are the adverse effects of meningitis (ACWY®) vaccine?
- Menveo®
- Commonly reported reactions include injection site reactions (such as pain, erythema, induration, pruritus), headache, nausea, rash, and malaise.
- ACWY Vax®
- Generalized reactions to the quadrivalent vaccine are rare although pyrexia occurs more frequently in young children than in adults.
- Injection site reactions occur in approximately 10% of recipients and last for approximately 24–48 hours.
- Confirmed anaphylaxis after immunization is extremely rare, with anaphylactoid reactions reported for approximately 1 in every 500,000 doses.
In depth
© NHS Institute for Innovation and Improvement